ID
33483
Beschreibung
Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains Study conclusion, Pregnancy Information, Investigator Comment Log, Investigator's signature. It has to be filled in for the end of study.
Link
https://clinicaltrials.gov/ct2/show/NCT00599612
Stichworte
Versionen (2)
- 07.12.18 07.12.18 -
- 11.12.18 11.12.18 - Sarah Riepenhausen
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
11. Dezember 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Safety, tolerability, excretion balance and pharmacokinetics of Losmapimod in healthy males, NCT00599612
Study conclusion, Pregnancy Information, Investigator Comment Log, Investigator's signature
Beschreibung
Study conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008972
Beschreibung
day month year Refer to protocol section(s) to evaluate subject completion or withdrawal from the study. If subject completed the study 'Date of subject completion (or withdrawal)' must match the last scheduled study visit date. If the subject withdrew from the study 'Date of subject completion or withdrawal' is the date at which the investigator agreed, or determined, that the subject's participation in the study was over. Typically, this will be the date of the subject's last visit to the investigator but an alternative date of withdrawal may be used in the circumstances described below. In the event that the contact between subject and investigator is conducted remotely during the planned study period (as defined in the protocol, i.e., by phone, by mail or electronic e-mail) and the subject is deemed to have withdrawn or been withdrawn, the date of withdrawal is considered to be the date on which the investigatoris made aware of the withdrawal or makes the decision to withdraw the subject. In the event that the subject is lost to follow-up, the date of withdrawal is considered to be the last point at which the investigator had contact with the subject during the study period (as defined in the protocol). Note: An 'actual contact' is defined as an interaction between the subject and the investigator or investigator's designee, where the investigatorldesignee has the opportunity to query the subject about the subject's status. This would include clinic visits, telephone contacts or electronic e-mail.
Datentyp
date
Alias
- UMLS CUI [1]
- C1549507
- UMLS CUI [2,1]
- C0011008
- UMLS CUI [2,2]
- C0422727
Beschreibung
Subject's withdraw
Datentyp
text
Alias
- UMLS CUI [1]
- C2349954
Beschreibung
You must only tick ONE Primary reason for withdrawal If the subject is withdrawn from the study, only tick 'Investigator discretion' or 'Withdrew consent' if the reason for withdrawaldoes not fit into any of the other primary reason categories. Adverse event: Use this primary reason only if the subject discontinues medication and is withdrawn from the study due to an adverse event. If the subject was withdrawn due to an adverse event, confirm that details recorded correspond with details on the appropriate (Non-)Serious Adverse Event page. Protocol deviation Study closed/terminated: Use this primary reason only if the site is closed or the study is terminated by the sponsor. Lost to follow-up: In the event that the subject is lost to follow-up, the date of withdrawal is considered to be the last point at which the investigator had contact with the subject. Investigator discretion: Use this primary reason only if the subject discontinues from tile study at the investigator's discretion and none of the other reasons apply. Withdrew consent: Use this primary reason only if the subject discontinues from the study because consent has been withdrawn and none of the other reasons apply (e.g., subject found the travel time to the clinic too long and does not want to continue in the study). Only use 'specify' to provide detailed information which is not covered by predefined sub-reasons provided. Note: An 'actual contact' is defined as an interaction between the subject and the investigator or investigator's designee, where the investigatorldesignee has the opportunity to query the subject about the subject's status. This would include clinic visits, telephone contacts or electronic e-mail.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C0566251
Beschreibung
Investigator discretion, specification
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0008961
- UMLS CUI [1,2]
- C0022423
- UMLS CUI [2,1]
- C2349954
- UMLS CUI [2,2]
- C0566251
Beschreibung
Pregnancy Information
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
Beschreibung
Investigator Comment Log
Alias
- UMLS CUI-1
- C0008961
- UMLS CUI-2
- C0947611
Beschreibung
Investigator's signature
Alias
- UMLS CUI-1
- C2346576
Beschreibung
Confirmation complete data in CRF
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0750484
- UMLS CUI [1,2]
- C3899518
Beschreibung
Investigator's signature
Datentyp
text
Alias
- UMLS CUI [1]
- C2346576
Beschreibung
Investigator's name (print)
Datentyp
text
Alias
- UMLS CUI [1]
- C2826892
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Ähnliche Modelle
Study conclusion, Pregnancy Information, Investigator Comment Log, Investigator's signature
C0011008 (UMLS CUI [2,1])
C0422727 (UMLS CUI [2,2])
C0566251 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,2])
C2349954 (UMLS CUI [2,1])
C0566251 (UMLS CUI [2,2])
C0947611 (UMLS CUI-2)
C1516308 (UMLS CUI [1,2])
C3899518 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])